Pharmacy Program Updates Effective April 1, 2021

February 15, 2021
group-label
Button Group
size
md
orientation
horizontal
alignment
center
button-type
lh-button
variant
text
text
Pharmacy
media-label
label
link
Pharmacy
icon-position
right
full-width
false
full-width-mobile
false

Effective April 1, 2021, Blue Cross and Blue Shield of North Carolina (Blue Cross NC) will have changes to our pharmacy utilization management (UM) requirements.

Our UM requirements apply to all commercial members with pharmacy benefit coverage through Blue Cross NC. These changes do not affect State Health Plan, Federal Employee Program, Medicare Part D members or any self-funded employer groups that carve out pharmacy benefits to another pharmacy benefits manager (PBM).

Below is a summary of the changes:

New Requirements

lh-header-fill
true
lh-sticky-header-column
true
Impacted Medications Requirement
  • Oxycontin
Updated Quantity Limits on Oxycontin 60mg and 80mg from 4 tablets to 2 tablets per day.  This aligns with other Oxycontin strengths.
  • Carafate Suspension
  • Sucralfate Suspension
  • Nitrofurantoin Suspension
  • Furadantin Suspension
These drugs will require Prior Authorization (only for members greater than 11 years old)
  • Sorilux
  • Calcipotriene 0.005% foam (generic Sorilux)
  • Procysbi
These drugs will require Prior Authorization & Step Therapy
  • Keveyis
  • Copaxone
  • Northera
These drugs will require Prior Authorization, Step Therapy, and Quantity Limits
  • Oxervate
This drug will require Prior Authorization & Quantity Limits
  • Sucraid
This drug will require Prior Authorization & Quantity Limits
  • Thiola
  • Thiola EC
  • Syprine
  • Trientine
  • Clovique
  • Depen
These drugs will require Prior Authorization & Step Therapy
  • Austedo
  • Xenazine
  • Tetrabenazine
These drugs will require Quantity Limits (they have and will continue to require PA)